Stage 2 · Toolkit 2.8
Local Tolerance & Special Toxicity Studies
Manage route-specific and product-specific special toxicity studies.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Local Tolerance & Special Toxicity Studies.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Local Tolerance Study Plan
- Special Toxicity Study Justification Memo
- Route-Specific Risk Assessment
- Special Toxicity Report Review Checklist
- Local Tolerance Key Finding Summary
- Special Toxicity Decision Memo
Excel workbooks
- Special Toxicity Study Tracker
- Local Tolerance Findings Tracker
- Special Toxicity Evidence Matrix
- Source Data Reference Log
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.